Other notable approvals for people with rare diseases include, one) a whole new drug to deal with specific patients with Hutchinson-Gilford Progeria Syndrome and progeroid laminopathies, rare conditions brought on by selected genetic mutations that result in premature getting older, and, 2) a new drug to the treatment method of thyroid eye disease,